相关实验视频
Updated: Jun 24, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.4K
冲动动作的脑下控制:从帕金森病的深度大脑刺激的见解
Damian M Herz1, Michael J Frank2, Huiling Tan3
1Movement Disorders and Neurostimulation, Department of Neurology, Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany.
Brain : a journal of neurology
|June 13, 2024
概括
在帕金森病中,脑下丘脑核的深度大脑刺激有助于控制行为. 这项研究阐明了它如何影响决策和冲动控制,为神经疾病治疗提供了洞察力.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 认知科学 认知科学
背景情况:
- 基底,特别是亚体细胞核,对于通过皮质-亚体细胞反循环进行作用控制至关重要.
- 帕金森病涉及行动控制受损,使得亚thalamic 核治疗干预的关键目标.
研究的目的:
- 阐明动作控制的神经机制,特别是通过对帕金森病患者进行深度大脑刺激来控制行动的延迟.
- 提出一个统一的框架,将决策,认知和运动联系起来,并调和下丘脑深层大脑刺激对冲动性的影响.
主要方法:
- 涉及深度大脑刺激 (DBS) 来记录神经活动的翻译性研究,并将电刺激应用于帕金森病患者的亚thalamic核.
- 分析神经活动的空间,光谱和时间特征,以了解行动控制机制.
- 检查DBS在与决策和行动执行相关的不同处理窗口中的行为影响.
主要成果:
- 深度大脑刺激揭示了皮质-亚脑皮层网络中潜在的特定神经机制,这些神经机制在皮质-亚脑皮层网络中的行动延迟,对行为有因果影响.
- 亚thalamic DBS可以影响决策,可能导致更快,不那么深思熟虑的选择.
- 临床结果显示,在亚thalamic DBS 后,冲动控制障碍减少,尽管可能对决策速度产生影响.
结论:
- 亚thalamic深度大脑刺激提供了对人类大脑的行动控制,决策和冲动性的洞察.
- 在手术后观察到的冲动控制障碍的减少可以通过将DBS效应与多巴胺介导机制分离来解释.
- 这些发现对理解和治疗影响行动控制和决策的神经系统疾病有重大影响.
相关概念视频
Parkinson's Disease: Treatment
255
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
255
Parkinson's Disease: Overview
524
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
524

